Real Time Assays Show Differences in Neuraminidase Inhibitor Binding to Influenza Viruses
Author Information
Author(s): Susan Barrett, Peter G. Mohr, Peter M. Schmidt, Jennifer L. McKimm-Breschkin
Primary Institution: CSIRO Materials Science and Engineering
Hypothesis
Can a real-time assay distinguish between fast and slow binding of neuraminidase inhibitors to wild type and mutant influenza viruses?
Conclusion
The study found that the modified real-time assay can effectively differentiate between fast and slow binding of neuraminidase inhibitors, revealing important insights into viral resistance.
Supporting Evidence
- The study demonstrated that preincubation with inhibitors enhances binding to wild type viruses but has minimal effect on resistant mutants.
- Results indicated that the IC50 values for fast binding inhibitors did not change significantly with preincubation.
- The modified assay provides additional phenotypic information about the rate of inhibitor binding.
Takeaway
This study shows how scientists can tell if a medicine works quickly or slowly against flu viruses, which helps understand how some viruses become resistant to treatments.
Methodology
The study used a modified fluorescent enzyme inhibition assay to monitor changes in IC50s over time for various neuraminidase inhibitors against wild type and mutant influenza viruses.
Limitations
The study may not account for all variables affecting inhibitor binding and resistance across different influenza strains.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website